Dong Lü
Director/Board Member chez Mudanjiang Youbo Pharmaceutical Co., Ltd.
Profil
Dong Lü is currently a Member-Supervisory Board at Mudanjiang Youbo Pharmaceutical Co., Ltd.
Previously, he was a Non-Executive Director at 3SBio, Inc. from 2014 to 2017.
He also held positions as a Director at Shenyang Sunshine Pharmaceuticals Co., Ltd., a Member-Supervisory Board at Jiuzhitang Co., Ltd., and a Vice President at CITIC Industrial Investment Group Corp.
Ltd.
Dr. Lü received a graduate degree from Peking University in 2003 and a doctorate degree from China Pharmaceutical University in 2010.
Postes actifs de Dong Lü
| Sociétés | Poste | Début |
|---|---|---|
Mudanjiang Youbo Pharmaceutical Co., Ltd.
 Mudanjiang Youbo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Mudanjiang Youbo Pharmaceutical Co., Ltd. is a holding company that manufactures and sells pharmaceutical products. It focuses on development of Chinese medicine. Its products include injection, lipid-lowering tablets, and lactobacillin tablets. The company was founded in October 1995 and is headquartered in Mudanjiang, China. | Director/Board Member | - |
Anciens postes connus de Dong Lü
| Sociétés | Poste | Fin |
|---|---|---|
| 3SBIO INC. | Director/Board Member | 30/06/2017 |
| JIUZHITANG CO., LTD. | Director/Board Member | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Director/Board Member | - |
CITIC Industrial Investment Group Corp. Ltd.
 CITIC Industrial Investment Group Corp. Ltd. Financial ConglomeratesFinance CITIC Industrial Investment Group Corp. Ltd. engages in the investment in industries. It invests in elderly care service, agricultural, supply chain service of imported cards, trust, and aluminum wheel manufacturing enterprises. Its business activities include domestic trade, and information consulting services. The company was founded on November 11, 1988 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Formation de Dong Lü
| Peking University | Graduate Degree |
| China Pharmaceutical University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| 3SBIO INC. | Health Technology |
| JIUZHITANG CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Mudanjiang Youbo Pharmaceutical Co., Ltd. is a holding company that manufactures and sells pharmaceutical products. It focuses on development of Chinese medicine. Its products include injection, lipid-lowering tablets, and lactobacillin tablets. The company was founded in October 1995 and is headquartered in Mudanjiang, China. | Health Technology |
CITIC Industrial Investment Group Corp. Ltd.
CITIC Industrial Investment Group Corp. Ltd. Financial ConglomeratesFinance CITIC Industrial Investment Group Corp. Ltd. engages in the investment in industries. It invests in elderly care service, agricultural, supply chain service of imported cards, trust, and aluminum wheel manufacturing enterprises. Its business activities include domestic trade, and information consulting services. The company was founded on November 11, 1988 and is headquartered in Shanghai, China. | Finance |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
